Screener
Tarsus Pharmaceuticals, Inc. TARS Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$18.55M+8.8% | -$6.97M+72.3% | -$8.37M+63.8% | -$12.59M+46.3% | -$20.34M+38.9% | ||
| $800K+300% | $197K-10.5% | $202K+5.2% | $200K0.0% | $200K+100% | ||
| $13.29M+61.4% | $11.97M+72.7% | $14.31M+93.4% | $12.24M+65.1% | $8.23M+10.1% | ||
| $61.22M+308% | -$24.65M-19.4% | —— | —— | -$29.39M-104% | ||
| $4.07M+306% | $5.82M+886% | $6.36M+8,731% | $1.91M+577% | $1M-3.7% | ||
| —— | -$58.56M-67.6% | —— | -$4.74M— | -$51.7M-27.6% | ||
| $3.3M+69.2% | $1.2M-99.1% | $2.31M-21.0% | $2.56M+301% | $1.95M-95.4% | ||
| $102.4M— | -$82.01M-201% | $70.92M+190% | $16.08M+429% | —— | ||
| $57.15M+288% | -$30.47M-43.4% | —— | —— | -$30.39M-96.8% |
FAQ
- How much cash does Tarsus Pharmaceuticals, Inc. generate?
- Tarsus Pharmaceuticals, Inc. (TARS) generated -$13.5M in operating cash flow over the trailing twelve months.
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow?
- After $18.2M of capital expenditures, Tarsus Pharmaceuticals, Inc.'s free cash flow was -$24.9M over the trailing twelve months, up 70.5% year over year.
- Where does Tarsus Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
